| Literature DB >> 11857751 |
Susan Kupka1, Tímea Tóth, Maciej Wróbel, Ulrike Zeissler, Witold Szyfter, Krzysztof Szyfter, Grazyna Niedzielska, Jerzy Bal, Hans-Peter Zenner, István Sziklai, Nikolaus Blin, Markus Pfister.
Abstract
The A1555G mutation in the 12SrRNA gene has been associated with aminoglycoside induced and nonsyndromic sensorineural hearing impairment. In this study we analyzed Hungarian, Polish and German patients with nonsyndromic severe to profound hearing impairment of unknown origin for this mutation. The frequency of the A1555G mutation in the Hungarian hearing impaired population was below 1.8 %. Three out of 125 Polish patients carrying the A1555G mutation were identified. Among German patients one carrier was found (0.7 %) revealing a homoplastic A1555G mutation, whereas no mutation was detected in control individuals with normal hearing (frequency < 0.6%). In summary the frequencies of the A1555G mutation are low in the hearing impaired as well as in the normal population in Hungary, Poland and Germany. Since the importance of this mutation and its relationship with aminoglycoside exposure is not well understood yet, patients with nonsyndromic hearing impairment should be routinely screened for this mutation to avoid aminoglycoside induced hearing impairment due to increased sensitivity of maternal relatives. Copyright 2002 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11857751 DOI: 10.1002/humu.9017
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878